NO20021965L - Hydroksamsyrederivat som inhibitor av dannelse av opplöselig, human CD23 - Google Patents

Hydroksamsyrederivat som inhibitor av dannelse av opplöselig, human CD23

Info

Publication number
NO20021965L
NO20021965L NO20021965A NO20021965A NO20021965L NO 20021965 L NO20021965 L NO 20021965L NO 20021965 A NO20021965 A NO 20021965A NO 20021965 A NO20021965 A NO 20021965A NO 20021965 L NO20021965 L NO 20021965L
Authority
NO
Norway
Prior art keywords
inhibitor
formation
acid derivative
hydroxamic acid
soluble human
Prior art date
Application number
NO20021965A
Other languages
English (en)
Other versions
NO20021965D0 (no
Inventor
Andrew Faller
John Gerard Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20021965D0 publication Critical patent/NO20021965D0/no
Publication of NO20021965L publication Critical patent/NO20021965L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
NO20021965A 1999-10-27 2002-04-25 Hydroksamsyrederivat som inhibitor av dannelse av opplöselig, human CD23 NO20021965L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9925470.8A GB9925470D0 (en) 1999-10-27 1999-10-27 Novel compounds
PCT/EP2000/010649 WO2001030747A1 (en) 1999-10-27 2000-10-25 Hydroxamic acid derivative as inhibitor of the formation of soluble human cd23

Publications (2)

Publication Number Publication Date
NO20021965D0 NO20021965D0 (no) 2002-04-25
NO20021965L true NO20021965L (no) 2002-06-13

Family

ID=10863507

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021965A NO20021965L (no) 1999-10-27 2002-04-25 Hydroksamsyrederivat som inhibitor av dannelse av opplöselig, human CD23

Country Status (32)

Country Link
US (2) US6673965B1 (no)
EP (1) EP1224164B1 (no)
JP (1) JP3922431B2 (no)
KR (1) KR20020044578A (no)
CN (1) CN1182107C (no)
AR (1) AR026244A1 (no)
AT (1) ATE284382T1 (no)
AU (1) AU766072B2 (no)
BR (1) BR0015082A (no)
CA (1) CA2389319A1 (no)
CO (1) CO5261576A1 (no)
CZ (1) CZ20021424A3 (no)
DE (1) DE60016622T2 (no)
DK (1) DK1224164T3 (no)
ES (1) ES2233474T3 (no)
GB (1) GB9925470D0 (no)
GC (1) GC0000142A (no)
HK (1) HK1049146A1 (no)
HU (1) HUP0203270A3 (no)
IL (1) IL149364A0 (no)
MX (1) MXPA02004228A (no)
MY (1) MY133601A (no)
NO (1) NO20021965L (no)
NZ (1) NZ518566A (no)
PE (1) PE20010898A1 (no)
PL (1) PL356524A1 (no)
PT (1) PT1224164E (no)
SI (1) SI1224164T1 (no)
TW (1) TW561141B (no)
UY (1) UY26416A1 (no)
WO (1) WO2001030747A1 (no)
ZA (1) ZA200203255B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8722686B2 (en) * 2008-09-19 2014-05-13 Pfizer Inc. Hydroxamic acid derivatives useful as antibacterial agents
US8945575B2 (en) 2009-12-01 2015-02-03 Trustees Of Boston University Treatment of IgE-mediated disease
US8664401B2 (en) 2009-12-16 2014-03-04 Pfizer Inc. N-linked hydroxamic acid derivatives useful as antibacterial agents
CN104529883A (zh) 2011-03-07 2015-04-22 辉瑞大药厂 可用作抗菌剂的氟吡啶酮衍生物
CA2830866A1 (en) 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
US8748466B2 (en) 2011-04-08 2014-06-10 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents
EP2525213A1 (en) * 2011-05-16 2012-11-21 Renishaw plc Spectroscopic apparatus and methods for determining components present in a sample

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513331D0 (en) 1995-06-30 1995-09-06 British Biotech Pharm Matrix metalloproteinase inhibitors
GB9813451D0 (en) * 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
KR20020044578A (ko) 2002-06-15
TW561141B (en) 2003-11-11
CN1182107C (zh) 2004-12-29
GB9925470D0 (en) 1999-12-29
DE60016622D1 (de) 2005-01-13
MXPA02004228A (es) 2002-10-17
UY26416A1 (es) 2001-05-31
ES2233474T3 (es) 2005-06-16
JP2003512450A (ja) 2003-04-02
WO2001030747A1 (en) 2001-05-03
CN1411436A (zh) 2003-04-16
AR026244A1 (es) 2003-02-05
CO5261576A1 (es) 2003-03-31
HUP0203270A3 (en) 2003-11-28
SI1224164T1 (en) 2005-06-30
IL149364A0 (en) 2002-11-10
EP1224164B1 (en) 2004-12-08
MY133601A (en) 2007-11-30
CZ20021424A3 (cs) 2002-09-11
CA2389319A1 (en) 2001-05-03
NZ518566A (en) 2004-02-27
PL356524A1 (en) 2004-06-28
ATE284382T1 (de) 2004-12-15
AU766072B2 (en) 2003-10-09
HUP0203270A2 (hu) 2003-02-28
PT1224164E (pt) 2005-04-29
US20040077727A1 (en) 2004-04-22
AU1389501A (en) 2001-05-08
US6673965B1 (en) 2004-01-06
PE20010898A1 (es) 2001-10-13
DK1224164T3 (da) 2005-03-29
NO20021965D0 (no) 2002-04-25
HK1049146A1 (en) 2003-05-02
GC0000142A (en) 2005-06-29
DE60016622T2 (de) 2005-11-03
BR0015082A (pt) 2003-04-15
EP1224164A1 (en) 2002-07-24
ZA200203255B (en) 2003-03-20
JP3922431B2 (ja) 2007-05-30

Similar Documents

Publication Publication Date Title
NO20043158L (no) Substituerte kinazolinderivater som inhibitorer av aurorakinaser
NO20030867L (no) Hydroksamderivater anvendelig som deacetylaseinhibitorer
DK1460066T3 (da) Piperazinforbindelse som tachykinin-inhibitorer
DK1244647T3 (da) Quinzolinderivater som VIGF-inhibitorer
NO20010686L (no) Hydroksypipecolathydroksyaminsyrederivater som MMP inhibitorer
NO20021239D0 (no) Pteridinoner som kinase-inhibitorer
MA26812A1 (fr) Pyrimidine-2,4,6-triones inhibitrices de metalloproteinases
NO20013335L (no) Anvendelse av 4-H-1-benzopyran-4-on-derivater som inhibitorer av glatt muskelcelle proliferering
NO20021329D0 (no) Kinaseinhibitorer som terapeutiske midler
NO20031450L (no) Fumarsyrederivater som NF-kappa B inhibitorer
NO20031797D0 (no) Heteroarylalkylpiperazinderivater som fettsyreoksydasjonsinhibitorer
NO20021367L (no) Indolyl-3-glykosylsyrederivater som har terapeutisk verdifulle egenskaper
DE60043730D1 (de) Arylsulfonamid-substituierte hydroxamsäure-derivate
AU2001278986A1 (en) 3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors
NO20016201D0 (no) Tienopyrimidiner som fosfodiesteraseinhibitorer
NO20021959L (no) Tetrahydrotiopyranftalazinon-derivater som PDE4-inhibitorer
NO20021965L (no) Hydroksamsyrederivat som inhibitor av dannelse av opplöselig, human CD23
NO20022123D0 (no) Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
NO20043084L (no) 3-fenyl-2-arylalkyltiopropionsyre derivater som selektive agnoister av PPAR-ALPHA
NO20023921D0 (no) Derivater av thiazepinylhydroksamisk syre som inhibitorer av matriks metalloproteinase
ATE262517T1 (de) Thiopyranderivate as mmp-inhibitoren
NO20015033D0 (no) Anvendelse av maduraftalazinderivater som inhibitorer av proinflammatoriske cytokiner
NO20030820D0 (no) Anvendelse av vitamin D derivater som benresorpsjons inhibitorer
NO20006349D0 (no) Hydroksamsyrederivater som inhibitorer for produksjon av humant CD23 og av TNF-frigjöring
NO20022838L (no) Saccharinderivater som oralt aktive elastaseinhibitorer